Browse Anti-infective agents topic

Subtopics (41)

• Adverse and side effects
• Analysis
• Case studies
• Chemical properties
• Complications and side effects
• Conferences, meetings and seminars
• Consumption data
• Donations
• Dosage and administration
• Drug therapy
• Environmental aspects
• Evaluation
• Forecasts and trends
• Growth
• Health aspects
• Identification and classification
• Intellectual property
• Laws, regulations and rules
• Licensing agreements
• Licensing, certification and accreditation
• Market research
• Market size
• Marketing
• Physiological aspects
• Planning
• Political aspects
• Prices and rates
• Product development
• Product information
• Product introduction
• Public opinion
• Purchasing
• Reports
• Research
• Standards
• Statistics
• Supply and demand
• Surveys
• Technology application
• Testing
• Usage

Articles

Title	Author	Type	Date	Words
Antimicrobial silver in orthopedic and wound care products: the authors describe the use of silver in orthopedic devices and what you need to know.	Prince, Herbert N.; Prince, Daniel L.		May 1, 2008	4305
Cefriaxone sandwiched in 2007.			Apr 16, 2008	633
Optimer Pharmaceuticals Announces Peer-Reviewed Publication of OPT-80 Phase 1 Clinical Results for the Treatment of Clostridium Difficile Infection.			Apr 2, 2008	698
Antimicrobial peptides for use in oyster aquaculture: effect on pathogens, commensals, and eukaryotic expression systems.	Dorrington, Tarquin; Gomez-Chiarri, Marta	Report	Apr 1, 2008	8287
I-Flow Leads Infection Prevention Trend by Using Silver with Antimicrobial Properties in Medical Devices.			Mar 11, 2008	1298
CLSI Publishes Guideline for In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents.			Mar 7, 2008	414
Mycobacterium ulcerans disease, Peru.	Guerra, Humberto; Palomino, Juan Carlos; Falconi, Eduardo; Bravo, Francisco; Donaires, Ninoska; Van	Clinical report	Mar 1, 2008	3720
High rate of mobilization for [bla.sub.CTX-M]s.	Barlow, Miriam; Reik, Rebecca A.; Jacobs, Stephen D.; Medina, Monica; Meyer, Matthew P.; McGowan, Jo		Mar 1, 2008	4673
Lytix Raises $9 Million in Private Placement.			Dec 20, 2007	261
Abiomed Receives FDA Approval for the Combination iPulse(TM) Circulatory Support System.			Dec 19, 2007	596
Cubist Pharmaceuticals Launches New Product Web Site.		Website overview	Oct 3, 2007	531
Application of standard project management tools to research--a case study from a multi-national clinical trial.	Gist, Peter; Langley, David	Author abstract	Sep 22, 2007	2742
Data Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Demonstrate That INCB9471 is a Potent, Selective Inhibitor of the HIV-1 Virus with Excellent Pharmacokinetics Suitable for Once-Daily Dosing.		Conference news	Sep 18, 2007	882
Oculus Innovative Sciences Provides Update of Phase II Study for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers.		Clinical report	Sep 17, 2007	869
Oculus Innovative Sciences Microcyn Technology Data to be Presented by Researchers at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy.		Conference news	Sep 17, 2007	761
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125 and Other TLR9 Agonists.			Sep 17, 2007	759
Oculus Innovative Sciences to Conduct Conference Call Update on Phase II Study of Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers.			Sep 14, 2007	692
Safety and efficacy of antimicrobial mouthrinses in clinical practice.	DePaola, Louis G.; Spolarich, Ann Eshenaur		Sep 1, 2007	8526
Strategies for incorporating antimicrobial mouthrinses into daily oral care.	Asadoorian, Joanna		Sep 1, 2007	3927
Antimicrobial mouthrinses in contemporary dental hygiene practice: the take home message.	Darby, Michele Leonardi		Sep 1, 2007	825
Tests suggest new microbicide will have improved efficacy.			Sep 1, 2007	607
Novacta Biosystems Attracts New Investment.			Aug 7, 2007	356
Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom.	Suissa, Samy		Jul 1, 2007	5138
Chlamydophila psittaci transmission from pet birds to humans.	Cauwerts, Katty		Jul 1, 2007	1819
DuraBan Announces EPA Registration of Earth-Friendly Antimicrobial - Formula to Significantly Impact Green Building Materials and Other Markets.			Jun 28, 2007	496
Internet Advertising Revenues Soar Again, Near $5 Billion in Q1 07.			Jun 6, 2007	558
Consider chlorine dioxide as an antimicrobial treatment for surfaces and different food systems.			Jun 1, 2007	400
High levels of carbon dioxide do not increase effectiveness of antimicrobials in meat.			Jun 1, 2007	449
Enzon Pharmaceuticals, Bridgewater, NJ, May 21 (Silver Spring, MD).			Jun 1, 2007	331
Internet Advertising Revenues Grow 35% in '06, Hitting a Record Close to $17 Billion.			May 23, 2007	706
IAB Hosts Historic Summit on Interactive Audience Measurement.			May 22, 2007	981
Antimicrobial drugs and community-acquired Clostridium difficile--associated disease, UK.	Suissa, Samy		May 1, 2007	2337
Setbacks and steps forward in the search for safe and effective microbicides.	Patel, Bindiya Gillenwater		May 1, 2007	2206
The Interactive Advertising Bureau Challenges comScore and Nielsen//NetRatings in Open Letter.			Apr 20, 2007	2259
Complete Ban on All Growth-Promoting Antimicrobials in the EU Drives Growth in the Animal Feed Probiotics Market.			Apr 19, 2007	986
MRSA transmission between cows and humans.	Wagenaar, Jaap A.		Apr 1, 2007	2033
AIDS gel disappoints.		Brief article	Apr 1, 2007	283
Antimicrobials.			Mar 22, 2007	135
Antimicrobial prescribing patterns in a group of private primary health care clinics in South Africa.	Katende-Kyenda, Norah L.; Lubbe, Martie S.; Serfointein, Jan H.P.; Truter, Ilse	Report	Mar 1, 2007	4803
Decoding a protein to fend off sepsis.		Brief article	Dec 23, 2006	293
And AIDS help from the sea.		Brief article	Nov 1, 2006	104
Antimicrobial drugs in the home, United Kingdom.	Davey, Peter		Oct 1, 2006	3029
Oscient Pharmaceuticals Announces Results of FDA Advisory Committee Meeting for FACTIVE Tablets for the Treatment of Acute Bacterial Sinusitis.			Sep 13, 2006	1223
Oscient Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Discuss FACTIVE(R) sNDA for Acute Bacterial Sinusitis.			Sep 12, 2006	555
Bleach dilution system.		Brief article	Sep 1, 2006	52
Premier Purchasing Partners Signs New Agreement with J&J for BIOPATCH(TM) Antimicrobial Dressing.			Aug 30, 2006	127
Antimicrobial Cleaners OK'd In New York Despite Green Seal Prohibition.			Aug 29, 2006	375
Antiviral Therapeutics: Pipelines and Competitive Dynamics Report Surveys the 5 Major Viral Disease Categories and Their Sub-Indications.			Aug 18, 2006	688
OmniLytics Reports That FDA Amends Food Additive Regulations to Allow for Bacteriophage Use; Use of Bacteriophage for Listeria on Ready-to-Eat Meat and Poultry.			Aug 18, 2006	336
Big Pharma Has Rediscovered the Anti-Infectives Market and Is Bolstering Its Pipelines Through Licensing Agreements And Acquisitions - More Inside Infectious Diseases Report.			Aug 17, 2006	654
Milliken's Base Layers are Key to Hunting Success; New Fabrics Wick Perspiration and Feature Durable Anti-Microbial Technology.			Aug 10, 2006	1114
Covalent Group, Inc. Announces $1.7 Million Contract For Phase 2 Clinical Trial in Atherosclerosis.			Aug 7, 2006	866
CytoDyn Invited to Present at XVI World AIDS Conference.			Aug 4, 2006	799
Samsill Launches AgION-Treated Ring Binders; Safe, silver-based antimicrobial protects binders from bacteria, mold and other microbes.			Aug 2, 2006	766
New Company Plans to Market Microbicide by 2010; Tommy Thompson Chairs Instead Sciences.			Aug 1, 2006	783
Impact of ionizing radiation enhanced when used to treat biofilm bacteria.			Aug 1, 2006	397
Antimicrobial treatments.			Aug 1, 2006	220
MEDIVIR OUTLICENSES TWO NEW ANTIVIRAL PROJECTS TO TIBOTEC.			Aug 1, 2006	702
AgION Technologies Appoints Stuart R. Patterson as Chief Executive Officer; New leadership will capitalize on the company's momentum and accelerate adoption of company's innovative, silver-based, antimicrobial technology.			Jul 31, 2006	529
Research on Use of Ceragenins(TM) As Potential Therapy for Cystic Fibrosis Related Infections and Other Diseases to be Presented at ICAAC 2006.			Jul 26, 2006	837
Panacos to Report Second Quarter 2006 Results.			Jul 24, 2006	498
NanoViricides Achieving Recognition in the Biotech and Nanotech Industries for Its Nanotechnology-based Anti-viral Therapies.			Jul 18, 2006	494
Roche Releases New Pandemic Planning Guide for U.S.-Based Businesses; On-line Toolkit Designed to Help Navigate Key Issues, Aid Decision-Making.			Jul 17, 2006	1451
Gilead Sciences and the Institute of Organic Chemistry and Biochemistry (IOCB) Establish New Academic Research Centre in Prague; Donation by Gilead Honors Leadership of Dr. Antonin Holy in Antiviral Drug Discovery and Development.			Jul 13, 2006	656
Panacos Announces Promotion of Graham P. Allaway, Ph.D. to President and Chief Operating Officer.			Jul 11, 2006	523
Invisible defense protecting Virginia Tech.		Brief article	Jul 1, 2006	213
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of Acute Bacterial Sinusitis with FACTIVE Tablets.			Jun 28, 2006	1167
FermaVir Announces New Preclinical Oral Bioavailability Data for FV-100, its Clinical Candidate for Shingles; Data Confirms Excellent Oral Bioavailability of the ProDrug in Another Preclinical Model.			Jun 19, 2006	613
Panacos Presents Data on Lack of Clinical Resistance Development to Bevirimat (PA-457) at International HIV Drug Resistance Conference.			Jun 14, 2006	709
Aphios Awarded United States Patent for Antiviral Therapeutics.			Jun 13, 2006	428
Panacos Announces Initiation of Phase 2b Clinical Trial of First-In-Class HIV Maturation Inhibitor, Bevirimat (PA-457).			Jun 12, 2006	752
InSite Vision Announces the Issuance of an Additional US Patent on Azalide Ophthalmic Products.			Jun 7, 2006	756
FermaVir Announces FDA Response to its pre-IND Submission for Initial Bioavailability Studies in Human Clinical Trials of FV-100; Response Enables Company to Plan Clinical Development Program for Novel Antiviral Drug Candidate.			Jun 5, 2006	656
Panacos to Present at Pacific Growth Equities Life Sciences Growth Conference.			Jun 5, 2006	329
Panacos Announces Study Elucidating PA-457's Mechanism of Action Published in Journal of Virology;Findings Corroborate Novel Target and Support Further Maturation Inhibitor Development.			May 31, 2006	604
New Drug Futures Report Estimates That Anti-Infectives Grossed Sales of US$28.5 Billion in 2005.			May 31, 2006	512
Profectus BioSciences, Inc. Announces Additional $3 Million Private Placement of Equity Securities; Transaction to Accelerate the Development of Cell Cycle Agent Technologies and Other Enabling Antiviral Technologies.			May 30, 2006	303
Panacos to Present at Bear Stearns Biotech Confab.			May 25, 2006	322
Panacos to Present at Friedman Billings Ramsey 2006 Growth Investor Conference.			May 24, 2006	332
Alnylam and Collaborators Present Pre-Clinical Data for RNAi Therapeutics for the Treatment of Respiratory Diseases Including Pandemic Influenza; Results Include Data on Anti-viral Activity of RNAi Therapeutics toward H5N1 Virus.			May 23, 2006	1255
Geron and TA Therapeutics Announce Presentation of New Data Supporting Utility of Their Small Molecule Telomerase Activator TAT0002; TAT0002 Selected as Lead Compound for HIV/AIDS Indication.			May 15, 2006	821
Panacos Appoints Dr. Frederick Schmid Senior Vice President, Commercial Operations and Business Development.			May 15, 2006	646
FermaVir Announces a Presentation on Recent Results of its Clinical Candidate FV-100 for Shingles Therapy at 19th International Conference on Antiviral Research (ICAR) in San Juan, Puerto Rico.			May 10, 2006	450
AVI BioPharma Presents Initial Results on Hepatitis C Virus Clinical Trial at the International Conference on Antiviral Research Annual Meeting.			May 10, 2006	1180
Panacos to Present at Bank of America 2006 Health Care Conference.			May 10, 2006	305
AVI BioPharma Reports Preclinical Data Against Multiple Strains of Influenza; NEUGENE Antisense Efficacy Against Influenza Strains Reported at the International Conference on Antiviral Research.			May 9, 2006	1138
Panacos to Present at Rodman & Renshaw Third Annual Global Healthcare Conference.			May 9, 2006	309
GEN ID Lab Services, Inc. to Develop New Drug Candidates to Stop Death in Humans from the Avian Flu Virus (''Bird Flu'').			May 8, 2006	539
Adventrx completes merger with private firm.	Weeks, Katie		May 8, 2006	223
FermaVir Announces Presentations on Potential Shingles Therapy at 19th International Conference on Antiviral Research (ICAR); Research Enhances Preclinical Properties of FermaVir Compounds.			May 3, 2006	460
InSite Vision's AzaSite to Be Highlighted at ARVO Conference; Two Poster Presentations, Including a Second Anti-Infective Advisory Board Meeting.			May 2, 2006	1179
Samaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01A.			May 2, 2006	565
Ceragenix to Present at Rodman & Renshaw Third Annual Global Healthcare Conference.			May 1, 2006	303
Panacos Reports First Quarter 2006 Financial Results; PA-457 Phase 2b Trial Design Agreed with FDA; Study Projected to Begin in Q2 2006.			Apr 26, 2006	1494
Panacos to Present at Deutsche Bank Health Care Conference.			Apr 25, 2006	303
NanoViricides, Inc. Retires 833,600 Shares; Company Finalizes Agreement Regarding Return of Unauthorized Stock and Cancellation of Options.			Apr 19, 2006	329
Panacos to Report First Quarter 2006 Results.			Apr 19, 2006	400
Idenix licenses valopicitabine to Novartis.			Apr 1, 2006	949
Idenix licenses valopicitabine to Novartis.			Mar 1, 2006	952
G-spot sore spot.	Fugh-Berman, Adriane		May 1, 2005	454